IRIS
CHIMENTI, SERGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 44.683
EU - Europa 4.566
AS - Asia 2.544
AF - Africa 68
SA - Sud America 62
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 22
Totale 51.989
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 44.603
CN - Cina 965
SG - Singapore 916
UA - Ucraina 772
DE - Germania 748
IT - Italia 536
IE - Irlanda 480
SE - Svezia 404
FR - Francia 343
RU - Federazione Russa 318
GB - Regno Unito 307
FI - Finlandia 177
KR - Corea 174
PL - Polonia 150
IN - India 87
CA - Canada 68
NL - Olanda 55
BE - Belgio 47
ES - Italia 43
PK - Pakistan 43
ID - Indonesia 42
AU - Australia 40
JP - Giappone 40
BR - Brasile 38
HK - Hong Kong 36
TR - Turchia 34
CH - Svizzera 33
EG - Egitto 33
VN - Vietnam 32
IR - Iran 25
RO - Romania 25
TW - Taiwan 23
KG - Kirghizistan 21
UZ - Uzbekistan 21
EU - Europa 19
HU - Ungheria 17
PH - Filippine 17
IL - Israele 15
SK - Slovacchia (Repubblica Slovacca) 15
AE - Emirati Arabi Uniti 14
CZ - Repubblica Ceca 14
GR - Grecia 14
PT - Portogallo 13
EE - Estonia 10
NG - Nigeria 10
ZA - Sudafrica 10
MX - Messico 9
IQ - Iraq 8
AT - Austria 7
HR - Croazia 7
MY - Malesia 7
PE - Perù 7
CL - Cile 6
DK - Danimarca 6
LT - Lituania 6
TH - Thailandia 6
AR - Argentina 5
LV - Lettonia 5
NO - Norvegia 5
RS - Serbia 5
BJ - Benin 4
ET - Etiopia 4
MA - Marocco 4
NZ - Nuova Zelanda 4
CO - Colombia 3
EC - Ecuador 3
KW - Kuwait 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
CY - Cipro 2
LB - Libano 2
MD - Moldavia 2
OM - Oman 2
SA - Arabia Saudita 2
A1 - Anonimo 1
AM - Armenia 1
BD - Bangladesh 1
BH - Bahrain 1
CR - Costa Rica 1
GP - Guadalupe 1
KH - Cambogia 1
LK - Sri Lanka 1
MG - Madagascar 1
NA - Namibia 1
NP - Nepal 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 51.989
Salva come PNG Salva come JPEG
Città #
Woodbridge 13.836
Wilmington 10.937
Houston 9.548
Fairfield 1.612
Ann Arbor 1.279
Chandler 1.067
Ashburn 824
Singapore 778
Jacksonville 684
Seattle 674
Cambridge 569
Dublin 477
Medford 387
Dearborn 291
Beijing 290
Zhengzhou 265
New York 206
Lawrence 183
Santa Clara 182
Kraków 137
Rome 123
San Diego 98
Mülheim 87
Menlo Park 86
Shanghai 82
Boardman 72
Moscow 66
Redwood City 62
Munich 40
San Mateo 39
Hefei 38
Milan 37
Nanjing 35
London 33
Norwalk 32
Brussels 29
Jönköping 28
University Park 28
Guangzhou 27
Toronto 26
Falls Church 24
Jakarta 24
Verona 24
Hangzhou 21
Kunming 21
Madrid 20
Mountain View 20
Palo Alto 20
Nanchang 19
Dong Ket 18
Auburn Hills 17
Helsinki 17
Los Angeles 16
Tokyo 15
Duncan 14
Stockholm 14
Redmond 13
Detroit 12
Dubai 12
Fuzhou 12
Jinan 11
Melbourne 11
Ottawa 11
Phoenix 11
Budapest 10
Central 10
Lahore 10
Saint Petersburg 10
Salcedo 10
São Paulo 10
Cairo 9
Frankfurt am Main 9
Hounslow 9
Pune 9
Bucharest 8
Chengdu 8
Clearwater 8
Hanoi 8
Lagos 8
Naples 8
Nuremberg 8
Nürnberg 8
Paris 8
Taipei 8
Tallinn 8
Wuhan 8
Augusta 7
Bengaluru 7
Lima 7
Seoul 7
Trieste 7
Utrecht 7
Washington 7
Berlin 6
Chicago 6
Groningen 6
Hong Kong 6
Indiana 6
Islamabad 6
Leawood 6
Totale 45.974
Salva come PNG Salva come JPEG
Nome #
European S3-guidelines on the systemic treatment of psoriasis vulgaris 1.434
Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study 1.178
Atopic dermatitis and dental manifestations 484
AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa 478
Adalimumab for the treatment of severe psoriasis and psoriatic arthritis 465
Alopecia areata e trachionichia associato a sindrome da insufficienza endocrina plurighiandolare. 463
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 441
-174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers 439
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients 436
Effects of TNF-α and IL-1 β on the activation of genes related to inflammatory, immune responses and cell death in immortalized human HaCat keratinocytes 434
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study 434
Clinical aspects of the oral cavity in patients with psoriasis: an initial study and a proposal of a new evaluation method 433
Treatment of trachyonychia with tazarotene 429
Psoriasis, kaposi's sarcoma and hodgkin's disease in a patient with down's syndrome [2] 423
Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population 423
Tazarotene 0-1% gel for psoriasis of the fingernails and toenails: an open, prospective study [9] 422
Successful treatment of multiple filiform facial warts with imiquimod 5% cream in a patient infected by human immunodeficiency virus 421
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 420
New topical treatments for psoriasis 417
Tazarotene as alternative topical treatment for onychomycosis 417
Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with chronic hepatitis B [10] 415
Apremilast for the treatment of psoriasis. 415
Actinic keratosis treated with an immune response modifier: a case report of six patients 412
Experimental T cells immunotherapy by tumor-loaded ECP-generated dendritic antigen presenting cells 411
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 409
Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis 408
The significance of the development of antinuclear antibodies during infliximab treatment 404
Topical lactoferrin can improve stable psoriatic plaque 403
Reply to Scalone and Cortesi: ‘‘Cost-Utility Analysis of Biologic Therapies to Treat Chronic Plaque Psoriasis in Italy: The Importance of Using Updated and Adequate Social Tariffs to Calculate QALYs’’ 403
Lung nodule and facial erythematous plaques: a quiz 401
Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports 401
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target 399
Alopecia areata e trachionichia associato a sindrome da insufficienza indocrina plurighiandolare 399
Evaluation of clinical and ultrasonographic parameters in psoriatic arthritis patients treated with adalimumab: a retrospective study 398
Golimumab in Patients Affected by Moderate to Severe Psoriatic Arthritis: An Open-Label Study in Thirty-Two Patients Previously Treated with Other Biologics 398
Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis 395
Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population 395
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis 394
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 392
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy 391
Continuous treatment of plaque-type psoriasis with etanercept: An observational long-term experience 389
Chronic mucocutaneous candidiasis and alopecia areata as cutaneous expressions of autoimmune polyglandular syndrome type I 387
The impact of biologic therapy in chronic plaque psoriasis from a societal perspective: an analysis based on Italian actual clinical practice 387
Remission and time of resolution of nail psoriasis during infliximab therapy [27] 386
Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic performance of non-experts 385
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 384
Severe acne successfully treated with etanercept 384
Infliximab therapy induces increased polyclonality of CD4+CD25+ regulatory T cells in psoriasis. 384
Stress reactivity in psoriatic patients 382
PSORS2 markers are not associated with psoriatic arthritis in the Italian population 382
Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases 381
Local treatment of chronic cutaneous leg ulcers with recombinant human granulocyte-macrophage colony-stimulating factor. 381
Oral lichen planus: Novel acquisitions in the pathogenesis and treatment 381
Bullous dermatomyositis: A marker of poor prognosis and aggressive internal malignancy? 380
Phrynoderma: a cutaneous sign of an inadequate diet 378
Co-localization of susceptibility loci for psoriasis (PSORS4) and atopic dermatitis (ATOD2) on human chromosome 1q21 377
Topical use of calcitriol 3 microg/g ointment in the treatment of mild-to-moderate psoriasis: results from an open-label study 377
Treatment of lentigo maligna with tazarotene 0.1% gel 376
Characterization of the loricrin (LOR) gene as a positional candidate for the PSORS4 psoriasis susceptibility locus 374
High-dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: Efficacy, safety and impact on patients' quality of life 370
Bowenoid papulosis and invasive Bowen's disease: a multidisciplinary approach 370
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 369
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 367
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody 365
Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell carcinoma in seborrhoeic areas of the face 362
Melanoma-associated markers expression in blood: MUC-18 is associated with advanced stages in melanoma patients 362
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 362
What happened after the clinical trials: Long-term safety and efficacy of ustekinumab in daily clinical practice 360
Cerebriform plantar hyperplasia: the clinico-pathological hallmark of Proteus syndrome 359
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 357
Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness 354
A 2-year history of an asymptomatic scalp nodule - Cutaneous metastasis from renal cell carcinoma. 353
Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment 353
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis 353
Prevention of Dermatologic Side Effects of Bimatoprost 0.03% Topical Therapy 351
Zosteriform metastasis of occult bronchogenic carcinoma 351
Tofacitinib for the treatment of psoriasis 351
The first skin cancer screening day at the Italian parliament: A Euromelanoma initiative 349
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey 349
Metastatic Crohn's disease of the forehead 348
TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis 348
Disseminated pagetoid reticulosis presenting as cytotoxic CD4/CD8 double negative cutaneous T-cell lymphoma 342
Erysipeloid cutaneous metastasis from bladder carcinoma 341
Dermatitis artefacta in sporadic sclerodermoid hepatitis C virus-associated porphyria cutanea tarda 341
Influence and variation of the body mass index in patients treated with etancercept for psoriasis 341
Cyclosporine: a novel therapeutic approach for Burning Mouth Syndrome 339
Pyoderma vegetans and ulcerative colitis 336
Chronically Sun-damaged Melanomas Express Low Levels of Nuclear Glutathione-S-transferase-π: An Epidemiological and Clinicopathological Study in Italy 336
Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene 335
HIV-associated primary cutaneous anaplastic large cell lymphoma: A clinicopathological subset with more aggressive behavior? Case report and review of the literature 334
Small molecules and antibodies for the treatment of psoriasis: A patent review (2010–2015) 333
Ichthyosiform mycosis fungoides: A neoplastic acquired ichthyosis [5] 332
Immunologic biomarkers for clinical and therapeutic management of psoriasis 332
From patients’ needs to treatment outcomes in psoriasis: Results from the ‘pSORRIDI’ experience 332
Green sweating spots on hands and feet: unusual expression of hyperbilirubinemia 331
Zosteriform metastasis of occult bronchogenic carcinoma 330
Efficacy and safety of long-term infliximab therapy in moderate to severe psoriasis and psoriatic arthritis 329
Does metabolic syndrome influence psoriasis? 329
Insight into genetics of atopic dermatitis: future approaches and directions 328
Kaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia 328
Totale 40.001
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.061
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.061
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.439 0 0 0 0 0 1.364 1.157 1.198 1.073 1.105 674 868
2020/20217.104 777 802 745 867 634 674 794 695 313 240 409 154
2021/20222.158 88 275 151 139 59 177 104 115 146 186 142 576
2022/20232.793 260 230 142 409 236 586 183 156 290 27 172 102
2023/20241.156 120 52 81 50 105 290 81 106 23 38 25 185
2024/20251.896 177 811 438 263 113 94 0 0 0 0 0 0
Totale 52.787